Ultrastructural studies of platelet aggregates from human subjects receiving clopidogrel and from a patient with an inherited defect of an ADP-dependent pathway of platelet activation

被引:65
作者
Humbert, M
Nurden, P
Bihour, C
Pasquet, JM
Winckler, J
Heilmann, E
Savi, P
Herbert, JM
Kunicki, TJ
Nurden, AT
机构
[1] HOP CARDIOL, UMR 5533 CNRS, F-33604 PESSAC, FRANCE
[2] SANOFI RECH, F-31036 TOULOUSE, FRANCE
[3] Scripps Res Inst, DEPT VASC BIOL, LA JOLLA, CA USA
关键词
platelet aggregation; ADP; fibrinogen; GP IIb/IIIa complexes; clopidogrel;
D O I
10.1161/01.ATV.16.12.1532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our study investigated the effect of the antithrombotic drug clopidogrel (75 mg/d for 7 days) on the ultrastructure of platelet aggregates induced by ADP or 2-methylthio-ADP (2-MeS-ADP) in citrated platelet-rich plasma and examined the activation state of the GP IIb/IIIa complexes. Results were compared with those obtained for patient M.L., who has a congenital disorder characterized by a reduced and reversible platelet response to ADP. When untreated normal platelets were stimulated with high-dose ADP, electron microscopy revealed large and stable aggregates often surrounded by a layer of what appeared to be degranulated platelets. The reversible aggregates of platelets from subjects receiving clopidogrel or from patient M.L. did not show this layer. Electron microscopy showed that in both situations, the aggregates were composed of loosely bound platelets with few contact points. Immunogold labeling of ultrathin sections of Lowicryl-embedded aggregates formed by ADP or 2-MeS-ADP showed a much decreased platelet surface staining by (1) a polyclonal anti-fibrinogen antibody and (2) AP-6, a murine anti-ligand-induced binding site monoclonal antibody specific for GP IIb/IIIa complexes occupied with fibrinogen. Similar findings were seen after disaggregation, when many single platelets were present that showed no signs of secretion. Flow cytometry confirmed that the number of ligand-occupied GP IIb/IIIa complexes was much lower on platelets stimulated with ADP or 2-MeS-ADP after clopidogrel treatment. As expected from previous studies. ADP-induced platelet shape change and Ca2+ influx were unaffected by clopidogrel. These results agree with the hypothesis that platelet activation by ADP is biphasic and highlight a receptor-induced activation pathway affected by clopidogrel (or congenitally impaired in patient M.L.) that is necessary for the full activation of GP IIb/IIIa and the formation of stable macroaggregates.
引用
收藏
页码:1532 / 1543
页数:12
相关论文
共 52 条
  • [31] ADP CAUSES PARTIAL DEGRANULATION OF PLATELETS IN THE ABSENCE OF AGGREGATION
    JANES, SL
    WILSON, DJ
    COX, AD
    CHRONOS, NAF
    GOODALL, AH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (03) : 568 - 573
  • [32] KOUNS WC, 1994, BLOOD, V84, P1108
  • [33] BINDING OF 2-AZIDOADENOSINE [BETA-P-23]DIPHOSPHATE TO THE RECEPTOR ON INTACT HUMAN-BLOOD PLATELETS WHICH INHIBITS ADENYLATE-CYCLASE
    MACFARLANE, DE
    MILLS, DCB
    SRIVASTAVA, PC
    [J]. BIOCHEMISTRY, 1982, 21 (03) : 544 - 549
  • [34] 2-METHYLTHIOADENOSINE[BETA-P-32]DIPHOSPHATE - AN AGONIST AND RADIOLIGAND FOR THE RECEPTOR THAT INHIBITS THE ACCUMULATION OF CYCLIC-AMP IN INTACT BLOOD-PLATELETS
    MACFARLANE, DE
    SRIVASTAVA, PC
    MILLS, DCB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) : 420 - 428
  • [35] MAFFRAND JP, 1988, THROMB HAEMOSTASIS, V59, P225
  • [36] MILLS DCH, 1991, ARTERIOSCLER THROMB, V12, P430
  • [37] MUSTARD JF, 1978, BLOOD, V52, P453
  • [38] Distribution of ligand-occupied alpha(IIb)beta(3) in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6
    Nurden, P
    Humbert, M
    Piotrowicz, RS
    Bihour, C
    Poujol, C
    Nurden, AT
    Kunicki, TJ
    [J]. BLOOD, 1996, 88 (03) : 887 - 899
  • [39] AN INHERITED BLEEDING DISORDER LINKED TO A DEFECTIVE INTERACTION BETWEEN ADP AND ITS RECEPTOR ON PLATELETS - ITS INFLUENCE ON GLYCOPROTEIN IIB-IIIA COMPLEX FUNCTION
    NURDEN, P
    SAVI, P
    HEILMANN, E
    BIHOUR, C
    HERBERT, JM
    MAFFRAND, JP
    NURDEN, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) : 1612 - 1622
  • [40] PACKHAM MA, 1989, THROMB HAEMOSTASIS, V62, P968